Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Inactivated rotavirus vaccine induces protective immunity in gnotobiotic piglets.

Wang Y, Azevedo M, Saif LJ, Gentsch JR, Glass RI, Jiang B.

Vaccine. 2010 Jul 26;28(33):5432-6. doi: 10.1016/j.vaccine.2010.06.006. Epub 2010 Jun 15.

PMID:
20558244
2.
3.

Inactivated rotavirus vaccines: a priority for accelerated vaccine development.

Jiang B, Gentsch JR, Glass RI.

Vaccine. 2008 Dec 9;26(52):6754-8. doi: 10.1016/j.vaccine.2008.10.008. Epub 2008 Oct 23. Review.

PMID:
18951937
4.

The gnotobiotic piglet as a model for studies of disease pathogenesis and immunity to human rotaviruses.

Saif LJ, Ward LA, Yuan L, Rosen BI, To TL.

Arch Virol Suppl. 1996;12:153-61. Review.

PMID:
9015112
5.

Influence of potential protective mechanisms on the development of live rotavirus vaccines.

Ward RL, Clark HF, Offit PA.

J Infect Dis. 2010 Sep 1;202 Suppl:S72-9. doi: 10.1086/653549. Review.

PMID:
20684721
6.

Rotavirus vaccines and vaccination in Latin America.

Linhares AC, Bresee JS.

Rev Panam Salud Publica. 2000 Nov;8(5):305-31. Review.

PMID:
11190969
7.

A review of the current status of enteric vaccines.

Levine MM, Noriega F.

P N G Med J. 1995 Dec;38(4):325-31. Review.

PMID:
9522876
8.

Human rotavirus virus-like particle vaccines evaluated in a neonatal gnotobiotic pig model of human rotavirus disease.

Azevedo MP, Vlasova AN, Saif LJ.

Expert Rev Vaccines. 2013 Feb;12(2):169-81. doi: 10.1586/erv.13.3. Review.

PMID:
23414408
9.

Prospects for development of a rotavirus vaccine against rotavirus diarrhea in infants and young children.

Kapikian AZ, Flores J, Hoshino Y, Midthun K, Gorziglia M, Green KY, Chanock RM, Potash L, Sears SD, Clements ML, et al.

Rev Infect Dis. 1989 May-Jun;11 Suppl 3:S539-46. Review.

PMID:
2548276
10.

Protective effects of natural rotavirus infection.

Velázquez FR.

Pediatr Infect Dis J. 2009 Mar;28(3 Suppl):S54-6. doi: 10.1097/INF.0b013e3181967c03. Review.

PMID:
19252424
11.

Influence of oral polio vaccines on performance of the monovalent and pentavalent rotavirus vaccines.

Patel M, Steele AD, Parashar UD.

Vaccine. 2012 Apr 27;30 Suppl 1:A30-5. doi: 10.1016/j.vaccine.2011.11.093. Review.

PMID:
22520134
12.

The new pentavalent rotavirus vaccine composed of bovine (strain WC3) -human rotavirus reassortants.

Clark HF, Offit PA, Plotkin SA, Heaton PM.

Pediatr Infect Dis J. 2006 Jul;25(7):577-83. Review.

PMID:
16804425
13.

Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq.

Ciarlet M, Schödel F.

Vaccine. 2009 Dec 30;27 Suppl 6:G72-81. doi: 10.1016/j.vaccine.2009.09.107. Review.

PMID:
20006144
14.
15.

Group A rotavirus veterinary vaccines.

Saif LJ, Fernandez FM.

J Infect Dis. 1996 Sep;174 Suppl 1:S98-106. Review.

PMID:
8752298
16.

Immune responses to rotavirus infection and vaccination and associated correlates of protection.

Desselberger U, Huppertz HI.

J Infect Dis. 2011 Jan 15;203(2):188-95. doi: 10.1093/infdis/jiq031. Review. No abstract available.

18.

Contribution of Maternal Immunity to Decreased Rotavirus Vaccine Performance in Low- and Middle-Income Countries.

Mwila K, Chilengi R, Simuyandi M, Permar SR, Becker-Dreps S.

Clin Vaccine Immunol. 2017 Jan 5;24(1). pii: e00405-16. doi: 10.1128/CVI.00405-16. Print 2017 Jan. Review.

19.

Rotavirus immune responses and correlates of protection.

Angel J, Franco MA, Greenberg HB.

Curr Opin Virol. 2012 Aug;2(4):419-25. doi: 10.1016/j.coviro.2012.05.003. Epub 2012 Jun 5. Review.

20.

Rotavirus and rotavirus vaccines.

Glass RI, Bresee J, Jiang B, Parashar U, Yee E, Gentsch J.

Adv Exp Med Biol. 2006;582:45-54. Review.

PMID:
16802618

Supplemental Content

Support Center